Literature DB >> 6342774

New platinum complexes in clinical trials.

F H Lee, R Canetta, B F Issell, L Lenaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6342774     DOI： 10.1016/s0305-7372(83)80031-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  18 in total

1.  An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.

Authors:  C Ewen; A Perera; J H Hendry; C A McAuliffe; H Sharma; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Protein binding of five platinum compounds. Comparison of two ultrafiltration systems.

Authors:  W J van der Vijgh; I Klein
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group.

Authors:  M W DeGregorio; B L Lum; W M Holleran; B J Wilbur; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.

Authors:  E Tapazoglou; L Polin; T H Corbett; M al-Sarraf
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

Review 5.  The chemotherapy of posterior fossa tumors in childhood.

Authors:  H S Friedman; W J Oakes
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 6.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

7.  A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules.

Authors:  S Martino; B A Samal; A Singhakowinta; S Yoshida; M Mackenzie; J Jain; V K Vaitkevicius
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Identification of complement inhibitory activities of two chemotherapeutic agents using a high-throughput cell imaging-based screening assay.

Authors:  Lingjun Zhang; Yuriy Fedorov; Drew Adams; Feng Lin
Journal:  Mol Immunol       Date:  2018-06-15       Impact factor: 4.407

9.  A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma.

Authors:  B M Cantwell; C R Franks; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 10.  Adverse haematological complications of anticancer drugs. Clinical presentation, management and avoidance.

Authors:  D C Bodensteiner; G C Doolittle
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.